Research.Patient.info
Generalized anxiety disorder (GAD) research hub
3 indexed studies · 1 currently recruiting
- recruitingPhase I
A study to evaluate the safety of NTX-1955 in patients with generalised anxiety disorder
This study is testing a new drug, NTX-1955, for generalised anxiety disorder (GAD). We want to see if it's safe and how people react to it. Participants will take the drug or a dummy pill for two weeks.
United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to examine the effects of oral NTX-1955 on the brain in healthy adults.
This study is looking at how a new medicine, NTX-1955, affects the brain in healthy adults. It's an early-stage study to understand if it could one day help people with generalised anxiety disorder.
Netherlands - recruitingPHASE2
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
This study is looking at a new way to treat anxiety using a medication called psilocybin. It aims to see if it's safe, if people can tolerate it, and if it helps reduce severe anxiety symptoms in adults.
Canada